Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a clinical-stage biotech company with a market capitalization of $28 million, announced today positive outcomes from its Phase 1 ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

To stay up to date on Akari’s recent developments on the Webull Corporate Connect Services Platform, current Webull users can follow AKTX from the app on their smartphone or table device. To download ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...

President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...